Creation of the Biobank Related to Eye Disease

The purpose of this study is to develop a BioBank (a specialized lab) and collect blood, fluids and/or other tissue samples to study eye diseases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eye Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

William Beaumont Hospital

Royal Oak, Michigan, 48073, United States

About this study

The purpose of the Biobank related to eye disease at Beaumont Hospital is to help connect specialties and Specialists with each other, outside traditional limits of hospital or laboratory departments. The specimens (blood, fluids, and/or tissue samples) that will be collected from men, women and children will assist the researchers in a variety of studies on human eye diseases.

Research utilizing these specimens will allow for an increased understanding of the etiology, disease process, and response to treatments for various eye diseases, and will provide opportunities to subsequently improve our management decisions. Furthermore, projects that cross over between subspecialties are sparse and that is a limiting factor for the development of research that takes a more comprehensive approach.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All pediatric and adult patients age 0-99 years -

Exclusion criteria

All patients who do not agree to consent for collection of blood, fluids, tissue.

Patients who are cognitively impaired and are not able to verbalize understanding of the risks/benefits.

Treatment and study plan

Primary outcomes

To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies

Biobanks can be used for numberous discovery applications such as: identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization and validation of biomarkers that are predictive of disease and treatment.

Sponsors and collaborators

Lead sponsor

Kimberly Drenser

Other

Collaborators

Vision Research Foundation

Registry information

Acronym: BioBank

Important dates

Study start: 2009
Primary completion: 2017
Study completion: 2017
First posted: Nov 15, 2010
Registry last updated: Jan 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed